Bio Protocol vs DigiByte — how do they compare? Bio Protocol trades at Rp513.28 (market cap Rp1,15T, Rp256,3M 24h volume), while DigiByte trades at Rp44.67 (market cap Rp820,78M, Rp51,6M 24h volume). The key difference: Bio Protocol is far larger — about 1401.1× DigiByte's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 18,4B / 21B DGB (88%) for DigiByte. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and DigiByte for 22 Days on average.
| BIO | DGB | |
|---|---|---|
Market Cap | Rp1,15T | Rp820,78M |
Volume (24h) | Rp256,3M | Rp51,6M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 18,4B / 21B DGB (88%) |
Typical Hold Time | 16 Days | 22 Days |
What Pluang investors did over the last 30 days
No sentiment data available yet.
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →DigiByte (DGB) is an open-source blockchain and asset creation platform. Its development started in October 2013, and its genesis block was mined in January 2014 as a fork of Bitcoin (BTC).
Read more on DGB →